Horizon Therapeutics Public Ltd Co

Neuberger Berman Group LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

173,122

Value ($000)

20,029

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	20,029	0.0%	173,122	9/30/2023
2023 Q2	8/11/2023	27,598	0.0%	268,337	6/30/2023
2023 Q1	5/12/2023	36,161	0.0%	331,324	3/31/2023
2022 Q4	2/13/2023	79,679	0.1%	700,166	12/31/2022
2022 Q3	11/15/2022	94,013	0.1%	1,519,040	9/30/2022
2022 Q2	8/15/2022	38,322	0.0%	480,463	6/30/2022
2022 Q1	5/23/2022	39,381	0.0%	374,307	3/31/2022
2021 Q4	2/11/2022	37,092	0.0%	344,930	12/31/2021
2021 Q3	11/12/2021	47,829	0.0%	437,319	9/30/2021
2021 Q2	8/13/2021	40,883	0.0%	437,218	6/30/2021
2021 Q1	5/13/2021	39,633	0.0%	431,184	3/31/2021
2020 Q4	2/10/2021	32,843	0.0%	448,983	12/31/2020
2020 Q3	11/12/2020	26,959	0.0%	347,053	9/30/2020
2020 Q2	8/13/2020	14,326	0.0%	257,750	6/30/2020
2020 Q1	5/14/2020	2,370	0.0%	80,000	3/31/2020
2019 Q4	2/12/2020	2,639	0.0%	72,900	12/31/2019